BiomX (PHGE) Research & Development (2019 - 2026)

BiomX has disclosed Research & Development across 8 years of filings, most recently posting -$315000.0 for Q1 2026.

• In Q1 2026, Research & Development fell 106.0% year-over-year to -$315000.0; the TTM figure through Mar 2026 stood at $15.7 million (down 39.06% YoY), while the FY2025 annual figure was $21.3 million, down 13.67% from the prior year.
• Research & Development came in at -$315000.0 for Q1 2026 at BiomX, down from $4.9 million in the prior quarter.
• In the past five years, Research & Development ranged from a high of $7.3 million in Q3 2024 to a low of -$315000.0 in Q1 2026.
• Average Research & Development over 5 years is $4.7 million, with a median of $4.9 million recorded in 2022.
• Year-over-year, Research & Development soared 138.58% in 2024 and tumbled 106.0% in 2026.
• Over 5 years, Research & Development stood at $3.2 million in 2022, then retreated by 16.28% to $2.7 million in 2023, then surged by 138.58% to $6.4 million in 2024, then dropped by 23.13% to $4.9 million in 2025, then plunged by 106.42% to -$315000.0 in 2026.
• Per Business Quant data, the three most recent Research & Development figures were -$315000.0 in Q1 2026, $4.9 million in Q4 2025, and $6.1 million in Q3 2025.